Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
Globe Newswire4-08-2023, 04:00
MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares 28-06-2023, 16:00
